REFERENCES
1. Murphy HR, Rayman G, Lewis K, et al. Effectiveness of continuous
glucose monitoring in pregnant women with diabetes: randomised clinical
trial. BMJ. 2008;337:a1680.
2. McLachlan K, Jenkins A, O’Neal D. The role of continuous glucose
monitoring in clinical decision-making in diabetes in pregnancy. Aust N
Z J Obstet Gynaecol. 2007;47:186-90.
3. Yogev Y, Chen R, Ben-Haroush A, et al. Continuous glucose monitoring
for the evaluation of gravid women with type 1 diabetes mellitus. Obstet
Gynecol. 2003;101:633-8.
4. Secher AL, Madsen AB, Ringholm L, et al. Patient satisfaction and
barriers to initiating real-time continuous glucose monitoring in early
pregnancy in women with diabetes. Diabet Med. 2012;29:272-7.
5. Yu Q, Aris IM, Tan KH, et al. Application and Utility of Continuous
Glucose Monitoring in Pregnancy: A Systematic Review. Front Endocrinol
(Lausanne). 2019;10:697.
6. Su JB, Wang XQ, Chen JF, et al. Glycemic variability in gestational
diabetes mellitus and its association with beta cell function.
Endocrine. 2013;43:370-5.
7. Nigam A, Sharma S, Varun N, et al. Comparative analysis of 2-week
glycaemic profile of healthy versus mild gestational diabetic pregnant
women using flash glucose monitoring system: an observational study.
BJOG. 2019;126 Suppl 4:27-33.
8. Dalfra MG, Sartore G, Di Cianni G, et al. Glucose variability in
diabetic pregnancy. Diabetes Technol Ther. 2011;13:853-9.
9. Yu W, Wu N, Li L, et al. A Review of Research Progress on Glycemic
Variability and Gestational Diabetes. Diabetes Metab Syndr Obes.
2020;13:2729-41.
10. Miller EM. Using Continuous Glucose Monitoring in Clinical Practice.
Clin Diabetes. 2020;38:429-38.
11. Battelino T, Danne T, Bergenstal RM, et al. Clinical Targets for
Continuous Glucose Monitoring Data Interpretation: Recommendations From
the International Consensus on Time in Range. Diabetes Care.
2019;42:1593-603.
12. Blum A. Freestyle Libre Glucose Monitoring System. Clin Diabetes.
2018;36:203-04.
13. Yamamoto JM, Murphy HR. Benefits of Real-Time Continuous Glucose
Monitoring in Pregnancy. Diabetes Technol Ther. 2021;23:S8-S14.
14. Huhn EA, Linder T, Eppel D, et al. Effectiveness of real-time
continuous glucose monitoring to improve glycaemic control and pregnancy
outcome in patients with gestational diabetes mellitus: a study protocol
for a randomised controlled trial. BMJ Open. 2020;10:e040498.
15. Yu F, Lv L, Liang Z, et al. Continuous glucose monitoring effects on
maternal glycemic control and pregnancy outcomes in patients with
gestational diabetes mellitus: a prospective cohort study. J Clin
Endocrinol Metab. 2014;99:4674-82.
16. Feig DS, Donovan LE, Corcoy R, et al. Continuous glucose monitoring
in pregnant women with type 1 diabetes (CONCEPTT): a multicentre
international randomised controlled trial. Lancet. 2017;390:2347-59.
17. Group. SKADMDftC. CONSORT 2010 Statement: updated guidelines for
reporting parallel group randomised trials. 2010.
18. International Association of D, Pregnancy Study Groups Consensus P,
Metzger BE, et al. International association of diabetes and pregnancy
study groups recommendations on the diagnosis and classification of
hyperglycemia in pregnancy. Diabetes Care. 2010;33:676-82.
19. Monnier L, Mas E, Ginet C, et al. Activation of oxidative stress by
acute glucose fluctuations compared with sustained chronic hyperglycemia
in patients with type 2 diabetes. JAMA. 2006;295:1681-7.
20. Teare MD, Dimairo M, Shephard N, et al. Sample size requirements to
estimate key design parameters from external pilot randomised controlled
trials: a simulation study. Trials. 2014;15:264.
21. Visser MM, Charleer S, Fieuws S, et al. Comparing real-time and
intermittently scanned continuous glucose monitoring in adults with type
1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised
controlled trial. Lancet. 2021;397:2275-83.
22. Wang S, Xin H, Li L, et al. Time in range measurements for
hyperglycemia management during pregnancy. Clin Chim Acta.
2022;531:56-61.
23. Preau Y, Armand M, Galie S, et al. Impact of Switching from
Intermittently Scanned to Real-Time Continuous Glucose Monitoring
Systems in a Type 1 Diabetes Patient French Cohort: An Observational
Study of Clinical Practices. Diabetes Technol Ther. 2021;23:259-67.
24. Heinemann L, Klonoff DC. An Opportunity to Increase the Benefit of
CGM Usage: The Need to Train the Patients Adequately. J Diabetes Sci
Technol. 2020;14:983-86.